Ken Fisher
BBIO icon

Ken Fisher’s BridgeBio Pharma BBIO Stock Holding History

Ken Fisher’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1M Buy
351,628
+119,227
+51% +$8.64M 0.01% 301
2025
Q4 		$17.8M Buy
+232,401
New +$15.3M 0.01% 339
2022
Q1 		– Sell
-763,531
Closed -$12.7M – 960
2021
Q4 		$12.7M Buy
763,531
+194,266
+34% +$8.22M 0.01% 357
2021
Q3 		$26.7M Buy
+569,265
New +$30.5M 0.02% 286

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ken Fisher's BBIO Position: Q1 2026 in Review

Ken Fisher increased its BridgeBio Pharma (BBIO) stake by 51% in Q1 2026, buying an estimated $8.64M and bringing the position to 351,628 shares worth $26.1M. The position accounts for 0.01% of the portfolio, ranked #301.

Ken Fisher first reported a position in BBIO in Q3 2021 and has held it in 4 quarters since. The position peaked at $26.7M in Q3 2021. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Ken Fisher held 351,628 shares of BridgeBio Pharma worth $26.1M as of Q1 2026.
  • Ken Fisher bought 119,227 BridgeBio Pharma shares in Q1 2026, an estimated $8.64M.
  • BridgeBio Pharma made up 0.01% of Ken Fisher's portfolio in Q1 2026, its #301 holding.
  • Ken Fisher first reported a position in BridgeBio Pharma in Q3 2021 and has held it in 4 quarters since.
  • Ken Fisher's BridgeBio Pharma position peaked at $26.7M in Q3 2021.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.